The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
MannKind Corporation(NASDAQ:MNKD) 
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. The company offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It...
Website: http://www.mannkindcorp.com
Founded: 1991
Full Time Employees: 232
Sector: Healthcare
Industry: Biotechnology
MannKind Days Payable Outstanding ttm (DPO)
MannKind Days Receivable Outstanding ttm (DSO)
MannKind Days Inventory Outstanding ttm (DIO)
MannKind Op Cashflow Per Share ttm
MannKind Free Cashflow Per Share ttm
MannKind Cash Per Share ttm
MannKind P/S ratio ttm
MannKind (GAAP) P/E ratio ttm
MannKind P/B ratio ttm
No extra charts and metrics for this ticker.